TMC Life Sciences Bhd operates in the General medical & surgical hospitals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares TMC Life Sciences Bhd with three other
health care providers in Asia:
Rajthanee Hospital PCL
sales of 1.21 billion Thai Bahts [US$35.23 million]
of which 100%
was Hospital business),
Ceylon Hospitals PLC
of Sri Lanka
(4.73 billion Sri Lanka Rupees [US$31.02 million]
Nawaloka Hospitals PLC
based in Sri Lanka
(5.86 billion Sri Lanka Rupees [US$38.44 million]
TMC Life Sciences Bhd reported sales of 129.21 million Malaysian Ringgits (US$29.89 million)
August of 2016.
increase of 25.2%
versus 2015, when the company's sales were 103.19 million Malaysian Ringgits.
Sales at TMC Life Sciences Bhd have increased during each of the previous five years
(and since 2011, sales have increased a total of 135%).